97 related articles for article (PubMed ID: 34211498)
1. IGFBP2 Is a Potential Master Regulator Driving the Dysregulated Gene Network Responsible for Short Survival in Glioblastoma Multiforme.
Kalya M; Kel A; Wlochowitz D; Wingender E; Beißbarth T
Front Genet; 2021; 12():670240. PubMed ID: 34211498
[TBL] [Abstract][Full Text] [Related]
2. [Master regulators associated with poor prognosis in glioblastoma multiforme].
Kalya MP; Beisbarth T; Kel A
Biomed Khim; 2021 May; 67(3):201-212. PubMed ID: 34142527
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.
Biswas A; Salvucci M; Connor K; Düssmann H; Carberry S; Fichtner M; King E; Murphy B; O'Farrell AC; Cryan J; Beausang A; Heffernan J; Cremona M; Hennessy BT; Clerkin J; Sweeney KJ; MacNally S; Brett F; O'Halloran P; Bacon O; Furney S; Verreault M; Quissac E; Bielle F; Ahmed MH; Idbaih A; Leenstra S; Ntafoulis I; Fabro F; Lamfers M; Golebiewska A; Hertel F; Niclou SP; Yen RTC; Kremer A; Dilcan G; Lodi F; Arijs I; Lambrechts D; Purushothama MK; Kel A; Byrne AT; Prehn JHM
J Neurooncol; 2023 Jun; 163(2):327-338. PubMed ID: 37237151
[TBL] [Abstract][Full Text] [Related]
4. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
[TBL] [Abstract][Full Text] [Related]
5. IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcγRIIB phosphorylation in glioblastoma.
Liu Y; Song C; Shen F; Zhang J; Song SW
PLoS One; 2019; 14(9):e0222999. PubMed ID: 31560714
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
7. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.
Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J
Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852
[TBL] [Abstract][Full Text] [Related]
8. Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma.
Yin W; Tang G; Zhou Q; Cao Y; Li H; Fu X; Wu Z; Jiang X
Front Genet; 2019; 10():419. PubMed ID: 31130992
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.
Michaelsen SR; Urup T; Olsen LR; Broholm H; Lassen U; Poulsen HS
J Neurooncol; 2018 May; 137(3):533-542. PubMed ID: 29305787
[TBL] [Abstract][Full Text] [Related]
10. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma.
Prasad B; Tian Y; Li X
Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483
[TBL] [Abstract][Full Text] [Related]
11. IGFBP2 promotes neural stem cell maintenance and proliferation differentially associated with glioblastoma subtypes.
Shen F; Song C; Liu Y; Zhang J; Wei Song S
Brain Res; 2019 Feb; 1704():174-186. PubMed ID: 30347220
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes.
Wang H; Wang H; Shen W; Huang H; Hu L; Ramdas L; Zhou YH; Liao WS; Fuller GN; Zhang W
Cancer Res; 2003 Aug; 63(15):4315-21. PubMed ID: 12907597
[TBL] [Abstract][Full Text] [Related]
13. The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA.
Lee CC; Chen PH; Ho KH; Shih CM; Cheng CH; Lin CW; Cheng KT; Liu AJ; Chen KC
PLoS One; 2017; 12(3):e0173890. PubMed ID: 28323865
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of high-throughput data to validate potential novel biomarkers and small molecule drugs for glioblastoma multiforme.
Qi F; Li Q; Lu X; Chen Z
J Int Med Res; 2020 Jul; 48(7):300060520924541. PubMed ID: 32634050
[TBL] [Abstract][Full Text] [Related]
15. High gene expression levels of VEGFA and CXCL8 in the peritumoral brain zone are associated with the recurrence of glioblastoma: A bioinformatics analysis.
Luo X; Xu S; Zhong Y; Tu T; Xu Y; Li X; Wang B; Yang F
Oncol Lett; 2019 Dec; 18(6):6171-6179. PubMed ID: 31788092
[TBL] [Abstract][Full Text] [Related]
16. Construction of Potential Glioblastoma Multiforme-Related miRNA-mRNA Regulatory Network.
Lou W; Ding B; Xu L; Fan W
Front Mol Neurosci; 2019; 12():66. PubMed ID: 30971889
[No Abstract] [Full Text] [Related]
17. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of IGFBP2 mRNA predicts poor survival in patients with glioblastoma.
Yuan Q; Cai HQ; Zhong Y; Zhang MJ; Cheng ZJ; Hao JJ; Wang MR; Wan JH
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138764
[TBL] [Abstract][Full Text] [Related]
19. Augmented expression of RUNX1 deregulates the global gene expression of U87 glioblastoma multiforme cells and inhibits tumor growth in mice.
Bogoch Y; Friedlander-Malik G; Lupu L; Bondar E; Zohar N; Langier S; Ram Z; Nachmany I; Klausner JM; Pencovich N
Tumour Biol; 2017 Apr; 39(4):1010428317698357. PubMed ID: 28443460
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of lncRNA-TF crosstalks and identification of prognostic regulatory feedback loops of glioblastoma using lncRNA/TF-mediated ceRNA network.
Ji Y; Gu Y; Hong S; Yu B; Zhang JH; Liu JN
J Cell Biochem; 2020 Jan; 121(1):755-767. PubMed ID: 31478223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
